To access this element change to forms mode OFF

Keyword Search

Search Results

Showing 1-1 of 1 record

GNT1163111 | A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy

GA ID:
Agency:
National Health and Medical Research Council (NHMRC)
Publish Date:
17-Jan-2019
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2021
Value (AUD):
$891,929.02
Recipient Name:
QIMR Berghofer Medical Research Institute
Last Updated:
17-Jan-2019 9:01 am (ACT Local Time)